Arcutis Biotherapeutics, Inc. ARQT
Set alert
32.07 USD +0.10 +0.31%
At close · Oct 30
31.82 -0.25 -0.78%
After hours · Oct 30, 6:21 PM ET
31.67 Day range 32.56
19.50 52-week range 32.82
- YTD
- +10.43%
- 1 year
- +28.69%
- Open
- 32.34
- Prev close
- 31.97
- Mkt cap
- 4.03B
- Vol
- 1.88M
- Avg vol
- 2.50M
- EPS
- 0.22
- P/E
- 145.77
- Div yield
- 0.00%
More statistics
- Low
- 31.67
- High
- 32.56
- Forward P/E
- 23.96
- Beta
- 1.58
- Short ratio
- 6.13
- Inst. own
- 108.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.53
- 200-d avg
- 25.22
- 1y target
- 39.13
MAX chart
Events in this range
- Aug 6, 2025Earnings: -0.13; estimate -0.18; surprise 27.78%
- Oct 28, 2025Earnings: 0.06; estimate -0.1; surprise 160%
- Feb 25, 2026Earnings: 0.13; estimate 0.03; surprise 333.33%
- May 6, 2026Earnings: -0.09; estimate -0.02; surprise -350%
- May 7, 2026Rating: Needham · Buy → Buy
- Aug 5, 2026Earnings: 0.11; estimate 0.05508; surprise 99.71%
- Aug 6, 2026Rating: Needham · Buy → Buy
- Aug 6, 2026Rating: Guggenheim · Buy → Buy
- Aug 6, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 15, 2026Rating: Cantor Fitzgerald · — → Overweight
- Oct 19, 2026Rating: Guggenheim · Buy → Buy
- Nov 4, 2026Earnings: —; estimate 0.18; surprise —%
Signals (132)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| RSI: Overbought | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Oct 27, 2025 | 1 year ago |
| RSI: Overbought | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 26, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 3, 2025 | 1 year ago |
| SMA: Bullish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 20, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Nov 25, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bullish | Sep 30, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| SMA: Bearish | Sep 23, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 23, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 8, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | May 6, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Jan 22, 2024 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 11, 2023 | 2 years ago |
| RSI: Oversold | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 10, 2023 | 3 years ago |
| RSI: Oversold | May 29, 2023 | 3 years ago |
| MACD: Sell Signal | May 15, 2023 | 3 years ago |
| SMA: Bearish | May 8, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 10, 2023 | 3 years ago |
| RSI: Oversold | Mar 13, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 30, 2023 | 3 years ago |
| SMA: Bullish | Jan 16, 2023 | 3 years ago |
| SMA: Bearish | Nov 21, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Sep 5, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | May 16, 2022 | 4 years ago |
| SMA: Bullish | May 16, 2022 | 4 years ago |
| SMA: Bearish | May 9, 2022 | 4 years ago |
| SMA: Bearish | May 9, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bullish | Feb 21, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 21, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 17, 2022 | 4 years ago |
| SMA: Bearish | Jan 10, 2022 | 4 years ago |
| MACD: Buy Signal | Dec 27, 2021 | 4 years ago |
| SMA: Bullish | Dec 20, 2021 | 4 years ago |
| RSI: Oversold | Nov 29, 2021 | 4 years ago |
| MACD: Sell Signal | Nov 15, 2021 | 4 years ago |
| SMA: Bearish | Oct 18, 2021 | 5 years ago |
| MACD: Buy Signal | Sep 27, 2021 | 5 years ago |
| SMA: Bullish | Sep 13, 2021 | 5 years ago |
| SMA: Bearish | Jun 14, 2021 | 5 years ago |
| SMA: Bullish | Jun 7, 2021 | 5 years ago |
| SMA: Bearish | May 10, 2021 | 5 years ago |
| SMA: Bearish | May 10, 2021 | 5 years ago |
| MACD: Sell Signal | May 10, 2021 | 5 years ago |
| MACD: Buy Signal | May 3, 2021 | 5 years ago |
| SMA: Bullish | Apr 26, 2021 | 5 years ago |
| SMA: Bullish | Apr 12, 2021 | 5 years ago |
| SMA: Bearish | Apr 5, 2021 | 5 years ago |
| MACD: Sell Signal | Mar 22, 2021 | 5 years ago |
| SMA: Bearish | Mar 15, 2021 | 5 years ago |
| SMA: Bullish | Feb 1, 2021 | 5 years ago |
| SMA: Bearish | Jan 18, 2021 | 5 years ago |
| SMA: Bullish | Dec 7, 2020 | 5 years ago |
| MACD: Buy Signal | Nov 30, 2020 | 5 years ago |
| SMA: Bullish | Nov 16, 2020 | 5 years ago |
| SMA: Bearish | Sep 21, 2020 | 6 years ago |
| SMA: Bullish | Sep 14, 2020 | 6 years ago |
| SMA: Bearish | Aug 24, 2020 | 6 years ago |
| SMA: Bearish | Jul 6, 2020 | 6 years ago |
| SMA: Bullish | Jun 15, 2020 | 6 years ago |
| SMA: Bearish | Jun 8, 2020 | 6 years ago |
| SMA: Bullish | May 18, 2020 | 6 years ago |
| SMA: Bearish | Apr 27, 2020 | 6 years ago |
| SMA: Bullish | Apr 20, 2020 | 6 years ago |
| SMA: Bearish | Apr 13, 2020 | 6 years ago |
| SMA: Bullish | Apr 6, 2020 | 6 years ago |
Key statistics
- Market cap
- 4.03B
- Enterprise value
- 3.89B
- Trailing P/E
- 145.77
- Forward P/E
- 23.96
- PEG ratio
- 0.00
- Price / sales
- 8.69
- Price / book
- 18.26
- EPS (TTM)
- 0.22
- Beta
- 1.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 6.15%
- Revenue (TTM)
- 463.98M
- Revenue growth
- 59.30%
- Free cash flow
- 21.69M
- Total cash
- 238.55M
- Total debt
- 114.14M
- Return on equity
- 15.86%
- Shares outstanding
- 125.69M
- Short % of float
- 17.38%
- 50-day average
- 26.53
- 200-day average
- 25.22
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 39.13 +22.0% upside
Now 32.07
- Target (low)
- 34.00
- Target (mean)
- 39.13
- Target (high)
- 48.00
Ratings (0m) 8 7 buy · 1 hold · 0 sell
- Strong buy2
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.16833.
Financials — quick view
ARQT Revenue — quarterly 129.86M
ARQT Net income — quarterly 15.01M
ARQT EPS — quarterly 0.11
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.18 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.05508 | 0.11 | +0.05 | +99.71% |
| May 6, 2026 | Mar 31, 2026 | -0.02 | -0.09 | -0.07 | -350.00% |
| Feb 25, 2026 | Dec 31, 2025 | 0.03 | 0.13 | +0.10 | +333.33% |
| Oct 28, 2025 | Sep 30, 2025 | -0.10 | 0.06 | +0.16 | +160.00% |
| Aug 6, 2025 | Jun 30, 2025 | -0.18 | -0.13 | +0.05 | +27.78% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Guggenheim | main | Buy | Buy |
| Oct 15, 2026 | Cantor Fitzgerald | init | — | Overweight |
| Aug 6, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Aug 6, 2026 | Guggenheim | main | Buy | Buy |
| Aug 6, 2026 | Needham | main | Buy | Buy |
| May 7, 2026 | Needham | reit | Buy | Buy |
About Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- arcutis.com
News
- Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings Growth
- Arcutis Appoints Rob Scott, MD to Board of Directors
- Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
- Guggenheim Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $44
- Why Is Arcutis Biotherapeutics Stock Surging Thursday?
- Cantor Fitzgerald Initiates Coverage On Arcutis Biotherapeutics with Overweight Rating, Announces Price Target of $48
- Arcutis Presents ZORYVE Data At EADV Congress
- Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
- Arcutis Biotherapeutics’ Subsidiary Arcutis Canada Secures Health Canada Approval For Roflumilast Cream In Pediatric Atopic Dermatitis Patients
- Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $38
Your note
Sign in to keep a note on ARQT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BURNETT PATRICK | Officer | Sale | Aug 18, 2026 | 117,592 |
| CHAUDHURI BHASKAR | Director | Stock Award(Grant) | Jun 11, 2025 | 917,807 |
| EDWARDS LARRY TODD | Officer | Sale | Mar 1, 2026 | 175,178 |
| HERON PATRICK J | Director | Stock Award(Grant) | Jun 4, 2026 | 8,868,640 |
| MATSUDA MASARU | Officer | Sale | Sep 7, 2026 | 116,182 |
| PEETZ CHRISTOPHER | Director | Stock Award(Grant) | Jul 14, 2026 | 191,815 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Montanova Capital LLC | 9.89% | 12,437,000 | 398.85M | Jun 29, 2026 |
| Blackrock Inc. | 8.39% | 10,545,466 | 338.19M | Jun 29, 2026 |
| Frazier Life Sciences Management, L.P. | 7.86% | 9,874,511 | 316.68M | Jun 29, 2026 |
| Rubric Capital Management LP | 6.58% | 8,271,577 | 265.27M | Jun 29, 2026 |
| Polar Capital Holdings PLC | 5.26% | 6,606,945 | 211.88M | Jun 29, 2026 |
| State Street Corporation | 4.63% | 5,822,840 | 186.74M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.42% | 6,810,517 | 218.41M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.84% | 3,564,957 | 114.33M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.40% | 3,020,203 | 96.86M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.35% | 2,959,244 | 94.90M | Sep 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 1.17% | 1,466,411 | 47.03M | Jul 30, 2026 |
| Prudential Jennison Small Co Fd., Inc.-PGIM JENNISON SMALL COMPANY Fd. | 1.10% | 1,386,237 | 44.46M | Jun 29, 2026 |